Cardiomyopathy

  1. Targeted Metabolomic Profiling of Carnitines Reveals Diagnostic Candidates in Postpartum Cardiomyopathy
    Targeted metabolomics study identifies altered carnitine profiles in postpartum cardiomyopathy, with acetylcarnitine and related species as potential diagnostic biomarker candidates.
  2. West-Norwegian PPCM incidence was low; recovery was successful
    Peripartum cardiomyopathy incidence, risk factors, and long-term clinical outcomes in a West-Norwegian population with comprehensive assessment of left ventricular recovery patterns.
  3. Ugandan women with peripartum cardiomyopathy had high mortality
    Prospective Ugandan cohort (n=80) with PPCM: baseline severe LV dysfunction, 7.5% six-month mortality, 10% intracardiac thrombus, 46.3% LV recovery; two-thirds received bromocriptine.